Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1993
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys
Y Yasutomi, S Koenig, S S Haun, et al.
Clinical and Vaccine Immunology : CVI
|
January 13, 2012
Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency
C Tkaczyk, L Hua, R Varkey, et al.
The Journal of Experimental Medicine
|
July 1, 1993
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine
C K Stover, G P Bansal, M S Hanson, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1999
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability
S Westbrock-Wadman, D R Sherman, M J Hickey, et al.
The Journal of Infectious Diseases
|
July 18, 2018
Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Antibody MEDI3902, Are Conserved Among Diverse Global Clinical Isolates
D E Tabor, V Oganesyan, A E Keller, et al.
Molecular Microbiology
|
October 29, 1998
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments
S N Coulter, W R Schwan, E Y Ng, et al.
Infection and Immunity
|
February 7, 1998
Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models
W R Schwan, S N Coulter, E Y Ng, et al.
Mbio
|
June 30, 2016
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease
C Tkaczyk, M M Hamilton, A Sadowska, et al.
Nature
|
June 6, 1991
New use of BCG for recombinant vaccines
C K Stover, V F de la Cruz, T R Fuerst, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2017
Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach
C Tkaczyk, S Kasturirangan, A Minola, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1993
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys
Y Yasutomi, S Koenig, S S Haun, et al.
Clinical and Vaccine Immunology : CVI
|
January 13, 2012
Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency
C Tkaczyk, L Hua, R Varkey, et al.
The Journal of Experimental Medicine
|
July 1, 1993
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine
C K Stover, G P Bansal, M S Hanson, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1999
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability
S Westbrock-Wadman, D R Sherman, M J Hickey, et al.
The Journal of Infectious Diseases
|
July 18, 2018
Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Antibody MEDI3902, Are Conserved Among Diverse Global Clinical Isolates
D E Tabor, V Oganesyan, A E Keller, et al.
Molecular Microbiology
|
October 29, 1998
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments
S N Coulter, W R Schwan, E Y Ng, et al.
Infection and Immunity
|
February 7, 1998
Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models
W R Schwan, S N Coulter, E Y Ng, et al.
Mbio
|
June 30, 2016
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease
C Tkaczyk, M M Hamilton, A Sadowska, et al.
Nature
|
June 6, 1991
New use of BCG for recombinant vaccines
C K Stover, V F de la Cruz, T R Fuerst, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2017
Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach
C Tkaczyk, S Kasturirangan, A Minola, et al.
Page
of 6